Jiao Liu

615 total citations · 1 hit paper
18 papers, 378 citations indexed

About

Jiao Liu is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiao Liu has authored 18 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiao Liu's work include Ferroptosis and cancer prognosis (4 papers), Inflammasome and immune disorders (4 papers) and Autophagy in Disease and Therapy (3 papers). Jiao Liu is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Inflammasome and immune disorders (4 papers) and Autophagy in Disease and Therapy (3 papers). Jiao Liu collaborates with scholars based in United States, China and France. Jiao Liu's co-authors include Daolin Tang, Rui Kang, Runliu Wu, Chunhua Yu, Brent R. Stockwell, Zhuan Zhou, Guido Kroemer, Xin Chen, Fangquan Chen and Hu Tang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Jiao Liu

16 papers receiving 378 citations

Hit Papers

Tumor-specific GPX4 degradation enhances ferroptosis-init... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiao Liu United States 9 190 175 117 80 50 18 378
Lichun Kang China 7 307 1.6× 199 1.1× 219 1.9× 83 1.0× 49 1.0× 9 478
Dominic Denk Germany 5 199 1.0× 142 0.8× 125 1.1× 123 1.5× 155 3.1× 7 460
Shi-Ping Lu China 6 189 1.0× 162 0.9× 118 1.0× 27 0.3× 31 0.6× 13 335
Zhaowei Zou China 11 283 1.5× 72 0.4× 148 1.3× 53 0.7× 78 1.6× 20 454
Shupeng Liu China 11 251 1.3× 85 0.5× 145 1.2× 46 0.6× 45 0.9× 27 382
Yanyan Zhang China 12 223 1.2× 68 0.4× 153 1.3× 43 0.5× 77 1.5× 20 347
Lingzhang Meng China 11 181 1.0× 58 0.3× 96 0.8× 83 1.0× 73 1.5× 42 358
Hechen Huang China 9 210 1.1× 80 0.5× 75 0.6× 127 1.6× 146 2.9× 11 422
Junqing Gan China 9 304 1.6× 128 0.7× 103 0.9× 85 1.1× 55 1.1× 13 390
Xiaoyan Gu China 14 373 2.0× 38 0.2× 243 2.1× 66 0.8× 49 1.0× 28 565

Countries citing papers authored by Jiao Liu

Since Specialization
Citations

This map shows the geographic impact of Jiao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Liu more than expected).

Fields of papers citing papers by Jiao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Liu. The network helps show where Jiao Liu may publish in the future.

Co-authorship network of co-authors of Jiao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiao Liu. A scholar is included among the top collaborators of Jiao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiao Liu. Jiao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Nian, Jiao Liu, Runliu Wu, et al.. (2025). A neuroimmune pathway drives bacterial infection. Science Advances. 11(18). eadr2226–eadr2226. 3 indexed citations
2.
Liu, Yuanda, Chang Liu, Fangquan Chen, et al.. (2025). AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer. Science Translational Medicine. 17(783). eadp4986–eadp4986. 13 indexed citations
3.
Wang, Nian, Jiao Liu, Runliu Wu, et al.. (2025). A non-canonical immunometabolic function of BRD3 during sepsis. Developmental Cell. 61(2). 322–339.e6.
4.
Zou, Ju, et al.. (2025). DAMPs in the immunogenicity of cell death. Molecular Cell. 85(20). 3874–3889. 2 indexed citations
5.
Chen, Fangquan, Rosa C. M. Y. Liang, Jieting Zhang, et al.. (2025). CYP51A1 in health and disease: from sterol metabolism to regulated cell death. Cell Death Discovery. 11(1). 322–322. 2 indexed citations
6.
Chen, Fangquan, et al.. (2025). CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. Nature Communications. 16(1). 2278–2278. 8 indexed citations
7.
Tang, Hu, Fangquan Chen, Limin Xiang, et al.. (2025). Ciprofloxacin enhances RSL3-induced ferroptosis by promoting mitochondrial Zn2+ accumulation via the STING1–CAV2 pathway. Journal of Biological Chemistry. 301(10). 110653–110653.
8.
Liu, Jiao, et al.. (2025). Differential ferroptosis regulation in red and white gastrocnemius under obesity and its Attenuation by exercise and dietary restriction. Scientific Reports. 15(1). 23821–23821. 3 indexed citations
9.
Chen, Fangquan, et al.. (2024). ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation. The International Journal of Biochemistry & Cell Biology. 175. 106646–106646. 1 indexed citations
10.
Chen, Fangquan, Hu Tang, Junhao Lin, et al.. (2024). Macropinocytosis inhibits alkaliptosis in pancreatic cancer cells through fatty acid uptake. Carcinogenesis. 45(12). 953–964. 6 indexed citations
11.
Chen, Fangquan, Junhao Lin, Rui Kang, Daolin Tang, & Jiao Liu. (2024). Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition. Molecular Carcinogenesis. 63(8). 1515–1527. 8 indexed citations
12.
Chen, Fangquan, Hu Tang, Junhao Lin, et al.. (2024). Targeting paraptosis in cancer: opportunities and challenges. Cancer Gene Therapy. 31(3). 349–363. 17 indexed citations
13.
Liu, Jiao, Daolin Tang, & Rui Kang. (2024). Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges. Trends in Pharmacological Sciences. 45(8). 666–670. 41 indexed citations
14.
Chen, Fangquan, et al.. (2024). Ciprofloxacin is a novel anti-ferroptotic antibiotic. Heliyon. 10(11). e32571–e32571. 2 indexed citations
15.
Liu, Jiao, Rui Kang, & Daolin Tang. (2024). Lipopolysaccharide delivery systems in innate immunity. Trends in Immunology. 45(4). 274–287. 38 indexed citations
16.
Liu, Jiao, Zhuan Zhou, Runliu Wu, et al.. (2023). Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Science Translational Medicine. 15(720). eadg3049–eadg3049. 171 indexed citations breakdown →
17.
Wu, Runliu, Jiao Liu, Daolin Tang, & Rui Kang. (2023). The Dual Role of ACOD1 in Inflammation. The Journal of Immunology. 211(4). 518–526. 16 indexed citations
18.
Wu, Runliu, Jiao Liu, Nian Wang, et al.. (2022). Aconitate decarboxylase 1 is a mediator of polymicrobial sepsis. Science Translational Medicine. 14(659). eabo2028–eabo2028. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026